World's Best Scientists 2026 revealed!
Sven-Ove Ögren

Sven-Ove Ögren

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Neuroscience 80 1640 1494 30 29 386 19216

Sven-Ove Ögren publications per year

The chart shows the history of publications by Sven-Ove Ögren between 1971 and 2021, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Sven-Ove Ögren published across 51 years, from 1971 to 2021, averaging 7.8 papers a year. Output peaked at 18 publications in 2004. 2 of the 397 publications appeared in the last two years.

No. of publications
5 10 15
Bar chart. Horizontal axis: year, 1971 to 2021. Vertical axis: number of publications, 0 to 18. Peak 18 publications in 2004. 1971: 1 publication 1972: 1 publication 1973: 0 publications 1974: 3 publications 1975: 5 publications 1976: 2 publications 1977: 5 publications 1978: 14 publications 1979: 8 publications 1980: 5 publications 1981: 13 publications 1982: 12 publications 1983: 11 publications 1984: 16 publications 1985: 15 publications 1986: 12 publications 1987: 8 publications 1988: 12 publications 1989: 4 publications 1990: 6 publications 1991: 8 publications 1992: 6 publications 1993: 9 publications 1994: 9 publications 1995: 6 publications 1996: 4 publications 1997: 14 publications 1998: 13 publications 1999: 4 publications 2000: 13 publications 2001: 6 publications 2002: 11 publications 2003: 11 publications 2004: 18 publications 2005: 15 publications 2006: 8 publications 2007: 13 publications 2008: 15 publications 2009: 17 publications 2010: 6 publications 2011: 12 publications 2012: 4 publications 2013: 5 publications 2014: 4 publications 2015: 6 publications 2016: 1 publication 2017: 2 publications 2018: 1 publication 2019: 1 publication 2020: 1 publication 2021: 1 publication
1971 2021

397 publications in total across all disciplines

View publications per year as a table
Sven-Ove Ögren: publications per year, 1971 to 2021
Year Publications
1971 1
1972 1
1973 0
1974 3
1975 5
1976 2
1977 5
1978 14
1979 8
1980 5
1981 13
1982 12
1983 11
1984 16
1985 15
1986 12
1987 8
1988 12
1989 4
1990 6
1991 8
1992 6
1993 9
1994 9
1995 6
1996 4
1997 14
1998 13
1999 4
2000 13
2001 6
2002 11
2003 11
2004 18
2005 15
2006 8
2007 13
2008 15
2009 17
2010 6
2011 12
2012 4
2013 5
2014 4
2015 6
2016 1
2017 2
2018 1
2019 1
2020 1
2021 1
Total 397
Download as CSV

Sven-Ove Ögren publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Sven-Ove Ögren sits on this spectrum.

No. of scientists
100 200 300 400 500
Bar chart with 86 bars. Horizontal axis: publications, 38–47 to 887+. Vertical axis: number of scientists, 0 to 539. Most scientists, 539, have 98–107 publications. The last bar groups every scientist with 887 publications or more. The highlighted bar, 378–387 publications, is where this scientist sits. 38–47 publications: 18 scientists 48–57 publications: 79 scientists 58–67 publications: 193 scientists 68–77 publications: 323 scientists 78–87 publications: 406 scientists 88–97 publications: 452 scientists 98–107 publications: 539 scientists 108–117 publications: 505 scientists 118–127 publications: 522 scientists 128–137 publications: 469 scientists 138–147 publications: 456 scientists 148–157 publications: 459 scientists 158–167 publications: 397 scientists 168–177 publications: 383 scientists 178–187 publications: 350 scientists 188–197 publications: 302 scientists 198–207 publications: 306 scientists 208–217 publications: 262 scientists 218–227 publications: 242 scientists 228–237 publications: 220 scientists 238–247 publications: 203 scientists 248–257 publications: 174 scientists 258–267 publications: 176 scientists 268–277 publications: 175 scientists 278–287 publications: 125 scientists 288–297 publications: 116 scientists 298–307 publications: 127 scientists 308–317 publications: 128 scientists 318–327 publications: 99 scientists 328–337 publications: 89 scientists 338–347 publications: 78 scientists 348–357 publications: 96 scientists 358–367 publications: 66 scientists 368–377 publications: 59 scientists 378–387 publications: 65 scientists 388–397 publications: 54 scientists 398–407 publications: 48 scientists 408–417 publications: 49 scientists 418–427 publications: 34 scientists 428–437 publications: 31 scientists 438–447 publications: 30 scientists 448–457 publications: 31 scientists 458–467 publications: 36 scientists 468–477 publications: 40 scientists 478–487 publications: 35 scientists 488–497 publications: 30 scientists 498–507 publications: 23 scientists 508–517 publications: 26 scientists 518–527 publications: 20 scientists 528–537 publications: 23 scientists 538–547 publications: 20 scientists 548–557 publications: 20 scientists 558–567 publications: 17 scientists 568–577 publications: 14 scientists 578–587 publications: 20 scientists 588–597 publications: 20 scientists 598–607 publications: 19 scientists 608–617 publications: 18 scientists 618–627 publications: 17 scientists 628–637 publications: 11 scientists 638–647 publications: 11 scientists 648–657 publications: 11 scientists 658–667 publications: 8 scientists 668–677 publications: 7 scientists 678–687 publications: 11 scientists 688–697 publications: 10 scientists 698–707 publications: 4 scientists 708–717 publications: 6 scientists 718–727 publications: 5 scientists 728–737 publications: 5 scientists 738–747 publications: 9 scientists 748–757 publications: 9 scientists 758–767 publications: 3 scientists 768–777 publications: 7 scientists 778–787 publications: 7 scientists 788–797 publications: 6 scientists 798–807 publications: 2 scientists 808–817 publications: 2 scientists 818–827 publications: 7 scientists 828–837 publications: 0 scientists 838–847 publications: 9 scientists 848–857 publications: 3 scientists 858–867 publications: 1 scientist 868–877 publications: 3 scientists 878–886 publications: 6 scientists 887+ publications: 100 scientists
38–47 publications 887+

This scientist: 386 publications — 90th percentile

90% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 887 publications or more.

View publications distribution as a table
Number of Neuroscience scientists by publication count, Research.com 2026 ranking edition. Based on 9,597 ranked scientists.
Publications Scientists This scientist
38–47 18
48–57 79
58–67 193
68–77 323
78–87 406
88–97 452
98–107 539
108–117 505
118–127 522
128–137 469
138–147 456
148–157 459
158–167 397
168–177 383
178–187 350
188–197 302
198–207 306
208–217 262
218–227 242
228–237 220
238–247 203
248–257 174
258–267 176
268–277 175
278–287 125
288–297 116
298–307 127
308–317 128
318–327 99
328–337 89
338–347 78
348–357 96
358–367 66
368–377 59
378–387 65 386
388–397 54
398–407 48
408–417 49
418–427 34
428–437 31
438–447 30
448–457 31
458–467 36
468–477 40
478–487 35
488–497 30
498–507 23
508–517 26
518–527 20
528–537 23
538–547 20
548–557 20
558–567 17
568–577 14
578–587 20
588–597 20
598–607 19
608–617 18
618–627 17
628–637 11
638–647 11
648–657 11
658–667 8
668–677 7
678–687 11
688–697 10
698–707 4
708–717 6
718–727 5
728–737 5
738–747 9
748–757 9
758–767 3
768–777 7
778–787 7
788–797 6
798–807 2
808–817 2
818–827 7
828–837 0
838–847 9
848–857 3
858–867 1
868–877 3
878–886 6
887+ 100
Download as CSV

Sven-Ove Ögren D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Sven-Ove Ögren sits on this spectrum.

No. of scientists
100 200 300 400 500
Bar chart with 68 bars. Horizontal axis: D-Index, 30–31 to 163+. Vertical axis: number of scientists, 0 to 512. Most scientists, 512, have 46–47 D-Index. The last bar groups every scientist with 163 D-Index or more. The highlighted bar, 80–81 D-Index, is where this scientist sits. 30–31 D-Index: 42 scientists 32–33 D-Index: 172 scientists 34–35 D-Index: 296 scientists 36–37 D-Index: 435 scientists 38–39 D-Index: 459 scientists 40–41 D-Index: 456 scientists 42–43 D-Index: 467 scientists 44–45 D-Index: 478 scientists 46–47 D-Index: 512 scientists 48–49 D-Index: 435 scientists 50–51 D-Index: 425 scientists 52–53 D-Index: 418 scientists 54–55 D-Index: 392 scientists 56–57 D-Index: 357 scientists 58–59 D-Index: 334 scientists 60–61 D-Index: 328 scientists 62–63 D-Index: 260 scientists 64–65 D-Index: 278 scientists 66–67 D-Index: 239 scientists 68–69 D-Index: 250 scientists 70–71 D-Index: 210 scientists 72–73 D-Index: 200 scientists 74–75 D-Index: 189 scientists 76–77 D-Index: 170 scientists 78–79 D-Index: 146 scientists 80–81 D-Index: 113 scientists 82–83 D-Index: 126 scientists 84–85 D-Index: 100 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 99 scientists 90–91 D-Index: 84 scientists 92–93 D-Index: 85 scientists 94–95 D-Index: 72 scientists 96–97 D-Index: 76 scientists 98–99 D-Index: 45 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 43 scientists 104–105 D-Index: 32 scientists 106–107 D-Index: 45 scientists 108–109 D-Index: 50 scientists 110–111 D-Index: 32 scientists 112–113 D-Index: 39 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 27 scientists 120–121 D-Index: 19 scientists 122–123 D-Index: 23 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 16 scientists 128–129 D-Index: 24 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 21 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 14 scientists 138–139 D-Index: 15 scientists 140–141 D-Index: 10 scientists 142–143 D-Index: 10 scientists 144–145 D-Index: 13 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 8 scientists 150–151 D-Index: 6 scientists 152–153 D-Index: 6 scientists 154–155 D-Index: 7 scientists 156–157 D-Index: 7 scientists 158–159 D-Index: 10 scientists 160–161 D-Index: 4 scientists 162 D-Index: 8 scientists 163+ D-Index: 100 scientists
30–31 D-Index 163+

This scientist: 80 D-Index — 83rd percentile

83% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 163 D-Index or more.

View D-Index distribution as a table
Number of Neuroscience scientists by D-index, Research.com 2026 ranking edition. Based on 9,597 ranked scientists.
D-Index Scientists This scientist
30–31 42
32–33 172
34–35 296
36–37 435
38–39 459
40–41 456
42–43 467
44–45 478
46–47 512
48–49 435
50–51 425
52–53 418
54–55 392
56–57 357
58–59 334
60–61 328
62–63 260
64–65 278
66–67 239
68–69 250
70–71 210
72–73 200
74–75 189
76–77 170
78–79 146
80–81 113 80
82–83 126
84–85 100
86–87 84
88–89 99
90–91 84
92–93 85
94–95 72
96–97 76
98–99 45
100–101 49
102–103 43
104–105 32
106–107 45
108–109 50
110–111 32
112–113 39
114–115 32
116–117 29
118–119 27
120–121 19
122–123 23
124–125 27
126–127 16
128–129 24
130–131 13
132–133 21
134–135 17
136–137 14
138–139 15
140–141 10
142–143 10
144–145 13
146–147 9
148–149 8
150–151 6
152–153 6
154–155 7
156–157 7
158–159 10
160–161 4
162 8
163+ 100
Download as CSV

Overview

What is he best known for?

The fields of study he is best known for:

  • Dopamine
  • Internal medicine
  • Neurotransmitter

Sven-Ove Ögren mainly investigates Internal medicine, Endocrinology, Dopamine, Pharmacology and Dopamine receptor D2. His Internal medicine study frequently links to other fields, such as Neuroscience. His Endocrinology study incorporates themes from Neuropeptide and Monoamine neurotransmitter, Serotonin.

His work in the fields of Dopamine, such as Dopaminergic, Dopamine receptor, Dopamine receptor D1 and Raclopride, intersects with other areas such as Offspring. The concepts of his Dopaminergic study are interwoven with issues in Neurturin, GDNF family of ligands and Anatomy. The various areas that Sven-Ove Ögren examines in his Pharmacology study include Striatum, Receptor, Postsynaptic potential, Zimelidine and Antidepressant.

His most cited work include:

  • Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo (1023 citations)
  • Specific in vitro and in vivo binding of 3H-raclopride a potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain (470 citations)
  • The selective dopamine D2 receptor antagonist raclopride discriminates between dopamine-mediated motor functions. (209 citations)

What are the main themes of his work throughout his whole career to date?

Sven-Ove Ögren mostly deals with Endocrinology, Internal medicine, Pharmacology, Neuroscience and Dopamine. The Endocrinology study combines topics in areas such as Agonist, Neuropeptide, Receptor, Galanin and Serotonin. His Receptor study combines topics in areas such as Cerebral cortex and Binding site.

Sven-Ove Ögren focuses mostly in the field of Internal medicine, narrowing it down to matters related to Desipramine and, in some cases, Neurotoxin. His research in Pharmacology focuses on subjects like Antidepressant, which are connected to Mechanism of action. His Dopamine receptor D2 research integrates issues from Dopaminergic and Catalepsy.

He most often published in these fields:

  • Endocrinology (46.61%)
  • Internal medicine (46.61%)
  • Pharmacology (42.37%)

What were the highlights of his more recent work (between 2000-2020)?

  • Internal medicine (46.61%)
  • Endocrinology (46.61%)
  • Pharmacology (42.37%)

In recent papers he was focusing on the following fields of study:

His primary areas of study are Internal medicine, Endocrinology, Pharmacology, Neuroscience and Galanin. His study in the field of Muscarinic acetylcholine receptor, Microdialysis, 5-HT receptor and Agonist also crosses realms of Behavioural analysis. His research integrates issues of AMPA receptor and Neuroprotection in his study of Endocrinology.

The study incorporates disciplines such as Dopamine receptor D2, Dopamine, Male mice and Antagonism in addition to Pharmacology. His work investigates the relationship between Dopamine receptor D2 and topics such as Dopaminergic that intersect with problems in Tyrosine hydroxylase. He interconnects Hippocampus, Acetylcholine and Cholinergic in the investigation of issues within Galanin.

Between 2000 and 2020, his most popular works were:

  • Acquisition, Expression, and Reinstatement of Ethanol-Induced Conditioned Place Preference in Mice: Effects of Opioid Receptor-Like 1 Receptor Agonists and Naloxone (153 citations)
  • Prenatal exposure to methylmercury changes dopamine-modulated motor activity during early ontogeny: age and gender-dependent effects. (84 citations)
  • Intraseptal muscarinic ligands and galanin: influence on hippocampal acetylcholine and cognition. (80 citations)

In his most recent research, the most cited papers focused on:

  • Dopamine
  • Neurotransmitter
  • Internal medicine

Sven-Ove Ögren focuses on Pharmacology, Endocrinology, Internal medicine, Dopamine and Neuroscience. His Pharmacology research is multidisciplinary, relying on both Male mice, Dopamine β hydroxylase, Anxiolytic and Zimelidine. His Endocrinology research is multidisciplinary, incorporating perspectives in Agonist and Galanin, Galanin receptor 2.

His research investigates the connection between Galanin and topics such as Microdialysis that intersect with issues in Acetylcholine and 5-HT receptor. His research in the fields of Dopaminergic and Dopamine receptor D2 overlaps with other disciplines such as Chlorphentermine. His studies deal with areas such as Antidepressant, 5-HT2A receptor, 5-HT6 receptor and Serotonergic as well as Dopamine receptor D2.

Best Publications

  • Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo

    A. Tomac;E. Lindqvist;L.-F. H. Lin;S. O. Ögren

  • Specific in vitro and in vivo binding of 3H-raclopride a potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain

    Christer Köhler;Håkan Hall;Sven-Ove Ögren;Lars Gawell

  • The role of 5-HT(1A) receptors in learning and memory.

    Sven Ove Ögren;Therese M. Eriksson;Elin Elvander-Tottie;Claudio D’Addario

  • Nociceptin/orphanin FQ microinjected into hippocampus impairs spatial learning in rats.

    Johan Sandin;Jeanette Georgieva;Pär A. Schött;Sven O. Ögren

  • The selective dopamine D2 receptor antagonist raclopride discriminates between dopamine-mediated motor functions.

    S O Ogren;H Hall;C Köhler;O Magnusson

  • Remoxipride, a new potential antipsychotic compound with selective anti-dopaminergic actions in the rat brain

    S.O. Ögren;H. Hall;C. Köhler;O. Magnusson

  • Reevaluation of the indoleamine hypothesis of depression. Evidence for a reduction of functional activity of central 5-HT systems by antidepressant drugs.

    S. O. Ögren;K. Fuxe;L. F. Agnati;Jan-Ake Gustafsson

  • Asphyctic lesion: proliferation of tyrosine hydroxylase-immunoreactive nerve cell bodies in the rat substantia nigra and functional changes in dopamine neurotransmission

    Börje Bjelke;Kurt Andersson;Sven Ove Ögren;Per Bolme

  • Acquisition, Expression, and Reinstatement of Ethanol-Induced Conditioned Place Preference in Mice: Effects of Opioid Receptor-Like 1 Receptor Agonists and Naloxone

    A. Kuzmin;J. Sandin;L. Terenius;S. O. Ögren

  • Time-dependent involvement of the dorsal hippocampus in trace fear conditioning in mice.

    Ilga Misane;Philip Tovote;Michael Meyer;Joachim Spiess

  • Chronic antidepressant treatment and central 5-HT synapses

    K. Fuxe;S.-O. Ögren;L.F. Agnati;F. Benfenati

  • Preparation of 11C-labelled Raclopride, a new potent dopamine receptor antagonist: preliminary PET studies of cerebral dopamine receptors in the monkey.

    Erling Ehrin;Lars Farde;Tomas de Paulis;Lars Eriksson

  • Adenosine A2A agonists: A potential new type of atypical antipsychotic

    Roberto Rimondini;Sergi Ferré;Sven Ove Ögren;Kjell Fuxe

  • Learning from the past and looking to the future: Emerging perspectives for improving the treatment of psychiatric disorders

    Mark J. Millan;Guy M. Goodwin;Andreas Meyer-Lindenberg;Sven Ove Ögren

  • On the in vivo and in vitro actions of fenfluramine and its derivatives on central monoamine neurons, especially 5-hydroxytryptamine neurons, and their relation to the anorectic activity of fenfluramine.

    Fuxe K;Farnebo Lo;Hamberger B;Ogren So

  • Gait Analysis of Adult Paraplegic Rats after Spinal Cord Repair

    Henrich Cheng;Henrich Cheng;Susanne Almström;Lydia Giménez-Llort;Robert Chang

  • Effects of ventral hippocampal galanin on spatial learning and on in vivo acetylcholine release in the rat

    Ogren So;Kehr J;Schött Pa

  • Phencyclidine- and dizocilpine-induced hyperlocomotion are differentially mediated.

    Sven Ove Ögren;Menek Goldstein

  • Evidence for a role of the neuropeptide galanin in spatial learning.

    S.O. Ögren;T. Hökfelt;K. Kask;Ü. Langel

  • Protective actions of human recombinant basic fibroblast growth factor on MPTP-lesioned nigrostriatal dopamine neurons after intraventricular infusion

    G. Chadi;A. Mø er;L. Rosen;A. M. Janson

  • Dopamine D1 receptor-mediated facilitation of GABAergic neurotransmission in the rat strioentopenduncular pathway and its modulation by adenosine A1 receptor-mediated mechanisms.

    Sergi Ferré;William T. O'Connor;Per Svenningsson;Lars Björklund

Frequent Co-Authors

Kjell Fuxe
Kjell Fuxe Karolinska Institute
Jan Kehr
Jan Kehr Karolinska Institute
Tamas Bartfai
Tamas Bartfai Stockholm University
Kurt Andersson
Kurt Andersson Karolinska Institute
Lars Terenius
Lars Terenius Karolinska Institute
Luigi F. Agnati
Luigi F. Agnati University of Modena and Reggio Emilia
Jan-Åke Gustafsson
Jan-Åke Gustafsson University of Houston
Bertil B. Fredholm
Bertil B. Fredholm Karolinska Institute
Gösta Jonsson
Gösta Jonsson Karolinska Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Sven-Ove Ögren

Trending Scientists

Recently Published Articles